Production assistance for cellular therapies (pact)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN268201600014I
- Awardee
-
Regents Of The University Of Minnesota UEI KABJZBBJ4B54
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 8 $3,477,960 obligated
Award facts
- Opportunity
-
- NHLBIECBHB201609JB Solicitation number
- Combined order value
- $3,477,960 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 8% used
- $45,630,651.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- 10 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health awarded a multiple-award indefinite delivery contract valued at $45.6 million to the Regents of the University of Minnesota, operating through its Office of Sponsored Projects Administration, for the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities program. This contract vehicle, awarded on July 29, 2016, with a completion date of June 30, 2022, provides cell manufacturing and process development services to support translational and clinical research in advanced cellular therapies. The University of Minnesota, a non-profit 1862 land-grant research institution, is leveraging its state-of-the-art cell processing capabilities and multidisciplinary scientific expertise at facilities located in Minneapolis and St. Paul, Minnesota. The contract utilizes a cost-no-fee pricing structure for most task orders, enabling the NHLBI to efficiently procure specialized cellular manufacturing services without contractor profit markup, thereby maximizing federal research investment.
Under this PACT-CPF master contract, the University of Minnesota has executed multiple delivery orders totaling approximately $3.5 million in cumulative value across six documented task orders spanning 2016 through 2022. These task orders support diverse cellular therapy initiatives, including manufacturing of mesenchymal stromal cells for clinical trials, development of peripheral blood-derived T-regulatory cells, production of human dermal fibroblast master cell banks and decellularized tissue scaffolds, preclinical development of induced T-regulatory cells, cryopreservation technical studies, and administrative and regulatory program support services. The delivery orders reflect the NHLBI's strategic investment in cell processing infrastructure and manufacturing expertise essential for advancing regenerative medicine research and supporting the National Institutes of Health's mission to develop next-generation cellular therapies for treating cardiovascular and hematologic diseases. All task orders were awarded without set-aside designations, indicating open competition among qualified contractors.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN268201600014I?
HHSN268201600014I was awarded to Regents Of The University Of Minnesota by National Heart Lung and Blood Institute (National Institutes of Health) on July 29, 2016.
How much is contract HHSN268201600014I worth?
Orders under HHSN268201600014I have obligated $3,477,960. HHSN268201600014I's own ceiling is $45,630,651.
How many orders have been placed under contract HHSN268201600014I?
8 orders have been placed under HHSN268201600014I, the latest on July 1, 2020.
Who can order from contract HHSN268201600014I?
HHSN268201600014I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN268201600014I part of a contract vehicle?
Yes. HHSN268201600014I is part of Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN268201600014I competed?
The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV